GNRH1 and ovarian hyperstimulation syndrome: Although not directly evaluating trigger strategies, a meta-analysis by Liu et al., including 52 studies and 9950 participants, demonstrated equivalent live birth rates between GnRH agonist and antagonist protocols, but with a reduced risk of OHSS in antagonist cycles, highlighting the strategic importance of trigger choice in this context [89].